Stay updated on Ixekizumab for Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.

Latest updates to the Ixekizumab for Bullous Pemphigoid Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and a recruitment status note states that the study is no longer looking for participants. The Interventions header has been reformatted to Intervention/Treatment and the page revision footer updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedRevision label on the page changed from v3.5.4 to v3.5.5. This indicates a backend release or patch update rather than a modification to study content or visible functionality.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.5.4 is now displayed on the page, replacing Revision: v3.5.3. This indicates a deployment version update of the site interface rather than a change to study content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a display/version change rather than any update to the clinical trial study details.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check96 days agoChange DetectedAdded Pemphigoid as a keyword and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Ixekizumab for Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab for Bullous Pemphigoid Clinical Trial page.